Purchase Order 75F40125P00078

Award Date 9/24/25
Potential Completion Date 9/28/26
Potential Value $150K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63110, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Malvern Panalytical Inc., a foreign-owned for-profit organization. The contract is for the delivery of a ZETASIZER OPTICAL PARTICLE ANALYZER with associated maintenance and service, with a ceiling value of $24,809.95 and a period of performance ending on September 14, 2026. The contract was awarded on July 10, 2025 and does not utilize any small business set-aside...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Wyatt Technology Corporation, a small business manufacturer of specialized analytical instrumentation and software. The $90,964.58 contract is for the provision of lab equipment, specifically multi-angle light scattering (MALS) detectors, field flow fractionation systems, dynamic light scattering instruments, and related software platforms. These highly precise scientific...
The Department of Health and Human Services Food and Drug Administration awarded a $323,129.68 firm fixed price purchase order to Agilent Technologies Inc. for a laser direct infrared imaging system to support compositional analysis of pharmaceutical products. The solicitation sought a system with capabilities including spectral matching, co-aligned visible and infrared images, and sample sizes up to 75mm to assist FDA in its regulatory responsibilities. Agilent Technologies will deliver the...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Scientific LLC, a manufacturer of scientific instruments, for a MALDI BIOTYPER SMART CM SYSTEM. The potential value of the order is $220,408.00. The system will be used by the FDA's Center for Biologics Evaluation and Research to identify and quantify bacterial species in complex samples as part of research and testing programs. This procurement is not set aside...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Malvern Panalytical Inc., a foreign-owned for-profit organization, for preventive maintenance services on an Epsilon 5 X-ray instrument. The fixed-price purchase order has a potential value of $100,141.97 and a completion date of September 15, 2024. The contract was not set aside for any particular business type. Malvern Panalytical is a company that specializes in analytical...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Malvern Panalytical Inc., a foreign-owned for-profit organization specializing in analytical instrumentation. The contract is for a preventative maintenance agreement (PMA) on a Malvern Panalytical Epsilon 5 Energy Dispersive X-Ray Fluorescence Spectrometer, with a base year (12 months) and one option period (12 months), for a total ceiling value of $44,132.73. The contract was awarded on July 26,...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price purchase order to Micromeritics Instrument Corporation, a small business manufacturer of scientific instruments and equipment, for the delivery of a Powder Rheometer System. The total potential value of the contract is $82,626.00 and the completion date is November 28, 2022. The original solicitation, which was not set aside, requested quotes for one powder rheometer system to be delivered to...
The U.S. Food and Drug Administration (FDA) awarded a $1,806,202.00 firm fixed price purchase order to Tescan USA Inc., a foreign-owned, for-profit organization, for the purchase, installation, training, and three-year extended service agreements for a TESCAN CLARA multi-vacuum field emission scanning electron microscope (SEM) with a gas monitor chamber and ion milling system. This advanced analytical instrument will be used by the FDA's Center for Drug Evaluation and Research, Office of...
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract valued at $139,383.28 to Malvern Panalytical Inc., a foreign-owned, for-profit organization, for the maintenance of a PANalytical Axios Wavelength-Dispersive X-Ray Fluorescence (XRF) Spectrometer. The contract has a base period and four 1-year option periods, with an ultimate completion date of September 13, 2025. The original solicitation was issued as a 100% small business set-aside, but the...
The U.S. Food and Drug Administration (FDA) awarded a $200,684.50 firm fixed-price purchase order contract to Waters Technologies Corporation, a manufacturer of advanced scientific instrumentation, for preventative and corrective maintenance on an Asymmetric Field Flow Fractionation (AFFF) system coupled with Multi Angle Light Scattering (MALS) unit, Differential Refractive Index Detector (DRI), and High Performance Liquid Chromatography (HPLC) system. The contract, which has a performance...

This is a 1-year, firm-fixed price purchase order awarded by the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), to Malvern Panalytical Inc. to provide a laser diffraction system to support the agency's testing and research on nonprescription spray drug products. The procurement, which follows FAR Part 12 and Part 13 procedures for commercial products and services, has a ceiling value of $150,052.01 and does not utilize a small business set-aside. The system, based on the Spraytec model manufactured by Malvern Panalytical, will be delivered and installed at the FDA facility in St. Louis, Missouri. This award is associated with a new procurement effort, as confirmed in the government's responses to vendor questions, and not a recompete of existing work.

Generated 9/25/25, 10:46 AM